Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 948-069-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From January 31 to March 19, 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study conducted in compliance with OECD Guideline No. 429 without any deviation.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
- Reference Type:
- other: Report Amendment 1
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- UK GLP Compliance Monitoring Programme (inspection date: 10 July 2012/ signed on 30 November 2012)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- (3aS,5aR,9aR,9bR)-Dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan
- Cas Number:
- 2006270-65-9
- Molecular formula:
- C16H28O
- IUPAC Name:
- (3aS,5aR,9aR,9bR)-Dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan
- Reference substance name:
- (3aR,5aS,9aS,9bS)-Dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan
- Cas Number:
- 68365-89-9
- Molecular formula:
- C16H28O
- IUPAC Name:
- (3aR,5aS,9aS,9bS)-Dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan
- Test material form:
- liquid
- Details on test material:
- Description: clear colourless liquid
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- - Storage conditions: room temperature in the dark
- Expiration date of the lot/batch: 2014-06-30
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca (CBA/CaOlaHsd)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Limited, Oxon, UK.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 15-23 g
- Housing: Animals were individually housed in suspended solid-floor polypropylene cages furnished with softwood wood flakes.
- Diet: Food (2014C Teklad Global Rodent diet supplied by Harlan Laboratories UK Ltd., Oxon, UK), ad libitum
- Water: Mains tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 19-25 °C
- Humidity: 30-70 %
- Air changes: Approximately 15 changes/h
- Photoperiod: 12 h dark / 12 h light
IN-LIFE DATES: From: 2014-01-31 To: 2014-03-19
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 100 % and 50 % v/v
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: For the purpose of the study, the test item was used undiluted and freshly prepared as a solution in acetone/olive oil 4:1. This vehicle was chosen as it produced the most suitable formulation at the required concentration.
-The mouse treated with undiluted test material showed a 10% body weight loss. Very slight erythema (score 1) was noted on both ears on Day 4. A maximum mean ear thickness increase of 23%, i.e. close to the threshold of 25%, was measured during the test, indicating that some irritation has occurred.
Based on this information the undiluted test item was selected for the main test.
MAIN STUDY - INITIAL TEST (100 %) & ADDITIONAL TEST (50 % v/v in 4/1 acetone/olive oil)
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Step-by-step individual approach, using tritiated (3H)-methyl thymidine, according to the OECD 429 test guideline. Due to mortality in the initial main test (100 %), an additional group of animals was treated with 50 μL (25 μL per ear) of the test item as a solution in acetone/olive oil 4:1 at a concentration of 50% v/v.
- Additional investigation: Measurement of ear thickness - The ear thickness of each ear was measured using a Mitutoyo 547-300S gauge (Mitutoyo Corporation) pre-dose and 1 hour post dose on Day 1, post dose on Days 2 and 3 and on Days 4 to 6. Any changes in the ear thickness were noted. Mean ear thickness changes were calculated between time period and every Day after. A mean ear thickness increase of equal to or greater than 25% was considered to indicate excessive irritation and limited biological relevance to the endpoint of sensitisation.
- Criteria used to consider a positive response: The test item will be regarded as a sensitizer if at least one concentration of the test item results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test item failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non-sensitizer."
TREATMENT PREPARATION AND ADMINISTRATION:
All formulations were used within two hours of preparation and assumed to be stable for this period. The concentration and homogeneity of the formulations were not determined by analysis. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Not applicable
Results and discussion
- Positive control results:
- A group of five animals was treated with 50 µl (25 µl per ear) of α-Hexylcinnamaldehyde, tech., 85% as a solution in acetone/olive oil 4:1 at a concentration of 25 % v/v. A further control group of five animals was treated with acetone/olive oil 4:1 alone. With a SI = 8.42, α-Hexylcinnamaldehyde, tech., 85% was considered to be a sensitizer under the conditions of the test.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 12.39
- Test group / Remarks:
- 100% in acetone/olive oil 4:1
- Key result
- Parameter:
- SI
- Value:
- 6.04
- Test group / Remarks:
- 50% in acetone/olive oil 4:1
- Key result
- Parameter:
- SI
- Value:
- 8.42
- Test group / Remarks:
- Positive control
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
Initial test: Mean DPM / animal for vehicle and 100% were 2236.38 and 27706.26, respectively.
Additional test: Mean DPM / animal for vehicle and 50% v/v were 4654.48 and 28121.18, respectively.
DETAILS ON STIMULATION INDEX CALCULATION
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows: 12.39 and 6.04 at 100 and 50% in acetone/olive oil 4:1, respectively.
EC3 CALCULATION : Not applicable.
CLINICAL OBSERVATIONS:
Initial test:
One animal treated with the undiluted test item (Animal Number 2-1) was humanely killed, on Day 4, due to the occurrence of clinical signs of toxicity that exceeded the moderate severity limit set forth in the UK Home Office Project Licence. Signs of systemic toxicity noted in this animal were hunched posture, lethargy and ptosis. This animal showed an 11% body weight loss. Very slight erythema (score 1) was noted on both ears of this animal on Days 1 to 3 and well-defined erythema (score 2) was noted on Day 4.
No signs of systemic toxicity were noted in the surviving test animals or control animals during the test. Very slight erythema (score 1) was noted in all surviving test animals on Days 1 to 4. Mean ear thickness increases up to 22% (Day 4), i.e. close to the threshold of 25%, were measured during the initial test, indicating that irritation has occurred.
Additional test:
There were no deaths. No signs of systemic toxicity or skin irritation were noted in the test or control animals during the test.
BODY WEIGHTS
Initial test:
Body weight change of the surviving test animals between Day 1 and Day 6 was comparable to that observed in the corresponding control group animals over the same period.
A slight body weight loss was noted in one surviving test group animal and one control group animal during the observation period but this was considered to be within an acceptable range for this Species/Strain and considered not to be of toxicological relevance.
Additional test:
Body weight change of the test animals between Day 1 and Day 6 was comparable to that observed in the corresponding control group animals over the same period.
A slight body weight loss was noted in one surviving test group animals and one control group animals during the observation period but this was considered to be within an acceptable range for this Species/Strain and considered not to be of toxicological relevance.
Any other information on results incl. tables
See the attached document for information on tables of results
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- Under the test conditions, test material is classified as a skin sensitizer according to the Regulation EC No. 1272/2008 (CLP) and to the GHS.
- Executive summary:
A study was performed to assess the skin sensitisation potential of test material in the CBA/Ca (CBA/CaOlaHsd) strain mouse following topical application to the dorsal surface of the ear. The method was conducted according to the OECD test guideline No 429 and in compliance with GLP. Following a preliminary screening test in a single animal in which no clinical signs of systemic toxicity or excessive local skin irritation were noted at a concentration of 100%, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. A group of five animals was treated with 50 μL (25 μL per ear) of the undiluted test item. A further group of five control animals were untreated. Due to mortality in the initial main test, an additional group of animals was treated with 50 μL (25 μL per ear) of the test item as a solution in acetone/olive oil 4:1 at a concentration of 50% v/v. A further group of five control animals was treated with acetone/olive oil 4:1 alone. The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1 to 6. The Stimulation Index values expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Test Item Treatment Group
Stimulation Index
Result
Initial Test 100%
12.39
Positive
Additional Test 50% v/v in acetone/olive oil 4:1
6.04
Positive
The historical positive control, α-Hexylcinnamaldehyde, gave a SI of 8.42, when tested at 25 % v/v. The test system was therefore considered to be valid.
No systemic toxicity or excessive local skin irritation were noted at a concentration of 50%, therefore this dose level was considered to be of biological relevance to the endpoint of skin sensitization.
Under the test conditions, test material is classified as a skin sensitizer in the Local Lymph Node Assay according to the Regulation (EC) No. 1272/2008 (CLP) and to the GHS.
This study is considered as acceptable and satisfies the requirement for sensitisation endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.